OLUMIANT

Drug Lilly USA, LLC
Total Payments
$8.8M
Transactions
20,130
Doctors
6,700
Companies
3

Payment Trends by Year

Year Amount Transactions Doctors
2024 $3.0M 9,993 4,119
2023 $3.8M 6,598 2,690
2022 $72,450 1,190 968
2021 $223,617 495 272
2020 $306,008 344 148
2019 $1.4M 1,510 346

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7.4M 4,382 84.4%
Consulting Fee $789,969 263 9.0%
Food and Beverage $482,740 14,295 5.5%
Travel and Lodging $79,916 1,185 0.9%
Unspecified $21,400 5 0.2%

Payments by Type

General
$8.8M
20,125 transactions
Research
$21,400
5 transactions

Top Doctors Receiving Payments for OLUMIANT

Doctor Specialty Location Total Records
, M.D. PH.D Dermatology Irvine, CA $160,929 105
, D.O Dermatology Nashville, TN $156,929 223
Omer Ibrahim Procedural Dermatology Chicago, IL $147,162 83
, MD Dermatology Columbia, MD $143,061 112
, MD Pediatric Dermatology Fairfield, CT $136,049 61
, M.D Dermatopathology Spartanburg, SC $128,059 101
, M.D Dermatology Boca Raton, FL $122,083 73
, MD Dermatology Middlebury, CT $121,437 38
, MD Dermatology Morristown, NJ $118,837 114
, M.D., M.S., A.H.E Dermatology Sacramento, CA $111,570 62
, M.D Dermatology Chicago, IL $107,459 57
, M.D Dermatology Exton, PA $104,281 103
, M.D Dermatology Encinitas, CA $103,340 65
, M.D Procedural Dermatology New York, NY $103,276 40
, M.D Dermatology Chicago, IL $97,104 79
, M.D Dermatology Monroe, WA $92,286 77
, DO Dermatology Roanoke, VA $90,516 81
, MD Dermatology San Francisco, CA $90,478 51
, M.D Dermatology Burlington, MA $89,432 54
, M.D MOHS-Micrographic Surgery Columbus, GA $88,205 74
, M.D., PH.D Dermatology Portland, OR $87,136 69
, M.D Rheumatology San Francisco, CA $86,441 93
Theodore Daly Garden City, NY $85,355 61
, MD Rheumatology New York, NY $81,824 57
, M.D Student in an Organized Health Care Education/Training Program New York, NY $79,395 101

About OLUMIANT

OLUMIANT is a drug associated with $8.8M in payments to 6,700 healthcare providers, recorded across 20,130 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.

Payment data is available from 2019 to 2024. In 2024, $3.0M was paid across 9,993 transactions to 4,119 doctors.

The most common payment nature for OLUMIANT is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7.4M, 84.4% of total).